Viewpoints in Clinical Proteomics - when will proteomics deliver clinically useful information?
- Department of Immunotechnology
Publishing year: 2012
Publication/Series: Proteomics Clinical Applications
Document type: Journal article
Publisher: John Wiley & Sons
Proteomics has not delivered biomarkers of clinical value, despite massive efforts. The technologies that are emerging today have, however, the power to reach deep into proteomes and to identify patterns associated with different diseases. The study design is then crucial and sample quality, bioinformatic approaches, pre-validation, using independent patient cohort, need to attract increased attention before proteomics will contribute to the needs of personalized medicine.
- Cell and Molecular Biology
- ISSN: 1862-8354
E-mail: carl [dot] borrebaeck [at] immun [dot] lth [dot] se